Novel drug discovery approaches for treating arenavirus infections

Expert Opin Drug Discov. 2016;11(4):383-93. doi: 10.1517/17460441.2016.1153626. Epub 2016 Mar 7.


Introduction: Arenaviruses are enveloped negative stranded viruses endemic in Africa, Europe and the Americas. Several arenaviruses cause severe viral hemorrhagic fever with high mortality in humans and pose serious public health threats. So far, there are no FDA-approved vaccines and therapeutic options are restricted to the off-label use of ribavirin. The major human pathogenic arenaviruses are classified as Category A agents and require biosafety level (BSL)-4 containment.

Areas covered: Herein, the authors cover the recent progress in the development of BSL2 surrogate systems that recapitulate the entire or specific steps of the arenavirus life cycle and are serving as powerful platforms for drug discovery. Furthermore, they highlight the identification of selected novel drugs that target individual steps of arenavirus multiplication describing their discovery, their targets, and mode of action.

Expert opinion: The lack of effective drugs against arenaviruses is an unmatched challenge in current medical virology. Novel technologies have provided important insights into the basic biology of arenaviruses and the mechanisms underlying virus-host cell interaction. Significant progress of our understanding of how the virus invades the host cell paved the way to develop powerful novel screening platforms. Recent efforts have provided a range of promising drug candidates currently under evaluation for therapeutic intervention in vivo.

Keywords: Arenavirus; LASV; LCMV; SKI-1/S1P; antiviral; envelope glycoprotein; high throughput screening; sensor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Arenaviridae Infections / drug therapy*
  • Arenaviridae Infections / epidemiology
  • Arenaviridae Infections / virology
  • Arenavirus / isolation & purification
  • Drug Design
  • Drug Discovery / methods*
  • Humans
  • Viral Vaccines / administration & dosage


  • Antiviral Agents
  • Viral Vaccines